메뉴 건너뛰기




Volumn 17, Issue 11, 2010, Pages 1175-1182

Vernakalant hydrochloride: A novel atrial-selective agent for the cardioversionof recent-onset atrial fibrillation in the emergency department

Author keywords

[No Author keywords available]

Indexed keywords

VERNAKALANT;

EID: 78349270201     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2010.00915.x     Document Type: Article
Times cited : (18)

References (25)
  • 1
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    • Go AS, Hylek EM, Phillips KA, et al., Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. JAMA. 2001; 285: 2370-5.
    • (2001) JAMA , vol.285 , pp. 2370-5
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3
  • 2
    • 33947249209 scopus 로고    scopus 로고
    • Novel anti-arrhythmic agents for the treatment of atrial fibrillation
    • Wettwer E, Christ T, Dobrev D, Ravens U,. Novel anti-arrhythmic agents for the treatment of atrial fibrillation. Curr Opin Pharmacol. 2007; 7: 214-8.
    • (2007) Curr Opin Pharmacol. , vol.7 , pp. 214-8
    • Wettwer, E.1    Christ, T.2    Dobrev, D.3    Ravens, U.4
  • 4
    • 0031777561 scopus 로고    scopus 로고
    • Evaluation and management of atrial fibrillation in the emergency department
    • Li H, Easley A, Barrington W, Windle J,. Evaluation and management of atrial fibrillation in the emergency department. Emerg Med Clin North Am. 1998; 16: 389-403.
    • (1998) Emerg Med Clin North Am. , vol.16 , pp. 389-403
    • Li, H.1    Easley, A.2    Barrington, W.3    Windle, J.4
  • 5
    • 0031085292 scopus 로고    scopus 로고
    • Management of supraventricular tachycardia in the emergency department
    • 24A
    • Connors S, Dorian P,. Management of supraventricular tachycardia in the emergency department. Can J Cardiol. 1997; 13 (suppl A): 19A-24A.
    • (1997) Can J Cardiol. , vol.13 , Issue.SUPPL. A
    • Connors, S.1    Dorian, P.2
  • 6
    • 37349082433 scopus 로고    scopus 로고
    • Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004
    • McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA Jr,. Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med. 2008; 51: 58-65.
    • (2008) Ann Emerg Med. , vol.51 , pp. 58-65
    • McDonald, A.J.1    Pelletier, A.J.2    Ellinor, P.T.3    Camargo, Jr.C.A.4
  • 8
    • 26044466519 scopus 로고    scopus 로고
    • Management of atrial fibrillation in the emergency department
    • Raghavan AV, Decker WW, Meloy TD,. Management of atrial fibrillation in the emergency department. Emerg Med Clin North Am. 2005; 23: 1127-39.
    • (2005) Emerg Med Clin North Am. , vol.23 , pp. 1127-39
    • Raghavan, A.V.1    Decker, W.W.2    Meloy, T.D.3
  • 9
    • 0038045264 scopus 로고    scopus 로고
    • Emergency management of atrial fibrillation
    • Wakai A, O'Neill JO,. Emergency management of atrial fibrillation. Postgrad Med J. 2003; 79: 313-9.
    • (2003) Postgrad Med J. , vol.79 , pp. 313-9
    • Wakai, A.1    O'Neill, J.O.2
  • 10
    • 34547666917 scopus 로고    scopus 로고
    • The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans
    • Dorian P, Pinter A, Mangat I, Korley V, Cvitkovic SS, Beatch GN,. The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans. J Cardiovasc Pharmacol. 2007; 50: 35-40.
    • (2007) J Cardiovasc Pharmacol. , vol.50 , pp. 35-40
    • Dorian, P.1    Pinter, A.2    Mangat, I.3    Korley, V.4    Cvitkovic, S.S.5    Beatch, G.N.6
  • 11
    • 33646003589 scopus 로고    scopus 로고
    • The role of late Ina and antiarrhythmic drugs in EAD formation and termination of Purkinje fibers
    • Fedida D, Orth PM, Hesketh JC, Ezrin AM,. The role of late Ina and antiarrhythmic drugs in EAD formation and termination of Purkinje fibers. J Cardiovasc Electrophysiol. 2006; 17: S71-8.
    • (2006) J Cardiovasc Electrophysiol. , vol.17 , pp. 71-8
    • Fedida, D.1    Orth, P.M.2    Hesketh, J.C.3    Ezrin, A.M.4
  • 12
    • 33644810948 scopus 로고    scopus 로고
    • The mechanism of atrial antiarrhythmic action of RSD1235
    • Fedida D, Orth PM, Chen JY, et al., The mechanism of atrial antiarrhythmic action of RSD1235. J Cardiovasc Electrophysiol. 2005; 16: 1227-38.
    • (2005) J Cardiovasc Electrophysiol. , vol.16 , pp. 1227-38
    • Fedida, D.1    Orth, P.M.2    Chen, J.Y.3
  • 13
    • 10644250949 scopus 로고    scopus 로고
    • A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation
    • Roy D, Rowe BH, Stiell IG, et al., A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. J Am Coll Cardiol. 2004; 44: 2355-61.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 2355-61
    • Roy, D.1    Rowe, B.H.2    Stiell, I.G.3
  • 14
    • 41149179489 scopus 로고    scopus 로고
    • Vernakalant hydrochloride for rapid conversion of atrial fibrillation: A phase 3, randomized, placebo-controlled trial
    • Roy D, Pratt CM, Torp-Pedersen C, et al., Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008; 117: 1518-25.
    • (2008) Circulation. , vol.117 , pp. 1518-25
    • Roy, D.1    Pratt, C.M.2    Torp-Pedersen, C.3
  • 15
    • 78349279044 scopus 로고    scopus 로고
    • Vernakalant hydrochloride injection for recent-onset atrial fibrillation: Summary from randomized, controlled trials and one open-label study [abstract]
    • Vidaillet HJ, Kavanagh KM, Kitt T, et al., Vernakalant hydrochloride injection for recent-onset atrial fibrillation: summary from randomized, controlled trials and one open-label study [abstract]. J Am Coll Cardiol. 2008; 51 (suppl A): A9.
    • (2008) J Am Coll Cardiol. , vol.51 , Issue.SUPPL. A , pp. 9
    • Vidaillet, H.J.1    Kavanagh, K.M.2    Kitt, T.3
  • 16
    • 28644444249 scopus 로고    scopus 로고
    • Management of arrhythmias in the emergency department
    • Hood RE, Shorofsky SR,. Management of arrhythmias in the emergency department. Cardiol Clin. 2006; 24: 125-33.
    • (2006) Cardiol Clin. , vol.24 , pp. 125-33
    • Hood, R.E.1    Shorofsky, S.R.2
  • 18
    • 34249722271 scopus 로고    scopus 로고
    • Incidence of early adverse events surrounding direct current cardioversion of persistent atrial fibrillation
    • Group of Pharmacology and Therapeutics of French Society of Cardiology
    • Guédon-Moreau L, Gayet JL, Galinier M, Frances Y, Lardoux H, Libersa C,; Group of Pharmacology and Therapeutics of French Society of Cardiology. Incidence of early adverse events surrounding direct current cardioversion of persistent atrial fibrillation. A cohort study of practices. Therapie. 2007; 62: 45-8.
    • (2007) A Cohort Study of Practices. Therapie. , vol.62 , pp. 45-8
    • Guédon-Moreau, L.1    Gayet, J.L.2    Galinier, M.3    Frances, Y.4    Lardoux, H.5    Libersa, C.6
  • 19
    • 36248999354 scopus 로고    scopus 로고
    • Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter
    • Stiell IG, Clement CM, Symington C, Perry JJ, Vaillancourt C, Wells GA,. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Acad Emerg Med. 2007; 14: 1158-64.
    • (2007) Acad Emerg Med. , vol.14 , pp. 1158-64
    • Stiell, I.G.1    Clement, C.M.2    Symington, C.3    Perry, J.J.4    Vaillancourt, C.5    Wells, G.A.6
  • 20
    • 77956691816 scopus 로고    scopus 로고
    • Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter
    • Stiell IG, Clement CM, Perry JJ, et al., Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter. CJEM. 2010; 12: 181-91.
    • (2010) CJEM , vol.12 , pp. 181-91
    • Stiell, I.G.1    Clement, C.M.2    Perry, J.J.3
  • 21
    • 34248664839 scopus 로고    scopus 로고
    • ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology
    • /American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
    • Fuster V, Rydén LE, Cannom DS, et al., ACC/ AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114: e257-354.
    • (2006) Circulation , vol.114 , pp. 257-354
    • Fuster, V.1    Rydén, L.E.2    Cannom, D.S.3
  • 22
    • 9444256916 scopus 로고    scopus 로고
    • Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and flutter: A dose-response study
    • Ellenbogen KA, Stambler BS, Wood MA, et al., Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and flutter: a dose-response study. J Am Coll Cardiol. 1996; 28: 130-6.
    • (1996) J Am Coll Cardiol. , vol.28 , pp. 130-6
    • Ellenbogen, K.A.1    Stambler, B.S.2    Wood, M.A.3
  • 23
    • 0029778315 scopus 로고    scopus 로고
    • Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators
    • Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT,. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation. 1996; 94: 1613-1621.
    • (1996) Circulation. , vol.94 , pp. 1613-1621
    • Stambler, B.S.1    Wood, M.A.2    Ellenbogen, K.A.3    Perry, K.T.4    Wakefield, L.K.5    Vanderlugt, J.T.6
  • 24
    • 0031760679 scopus 로고    scopus 로고
    • Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation
    • Abi-Mansour P, Carberry PA, McCowan RJ, Henthorn RW, Dunn GH, Perry KT,. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Am Heart J. 1998; 136: 632-42.
    • (1998) Am Heart J. , vol.136 , pp. 632-42
    • Abi-Mansour, P.1    Carberry, P.A.2    McCowan, R.J.3    Henthorn, R.W.4    Dunn, G.H.5    Perry, K.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.